In human-machine trust, humans rely on a simple averaging strategy.

Cogn Res Princ Implic

Psychological Sciences, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.

Published: September 2024

With the growing role of artificial intelligence (AI) in our lives, attention is increasingly turning to the way that humans and AI work together. A key aspect of human-AI collaboration is how people integrate judgements or recommendations from machine agents, when they differ from their own judgements. We investigated trust in human-machine teaming using a perceptual judgement task based on the judge-advisor system. Participants ( ) estimated a perceptual quantity, then received a recommendation from a machine agent. The participants then made a second response which combined their first estimate and the machine's recommendation. The degree to which participants shifted their second response in the direction of the recommendations provided a measure of their trust in the machine agent. We analysed the role of advice distance in people's willingness to change their judgements. When a recommendation falls a long way from their initial judgement, do people come to doubt their own judgement, trusting the recommendation more, or do they doubt the machine agent, trusting the recommendation less? We found that although some participants exhibited these behaviours, the most common response was neither of these tendencies, and a simple model based on averaging accounted best for participants' trust behaviour. We discuss implications for theories of trust, and human-machine teaming.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366733PMC
http://dx.doi.org/10.1186/s41235-024-00583-5DOI Listing

Publication Analysis

Top Keywords

machine agent
12
trust human-machine
8
human-machine teaming
8
second response
8
trusting recommendation
8
recommendation
5
human-machine trust
4
trust humans
4
humans rely
4
rely simple
4

Similar Publications

Placebo effect represents a serious confounder for the assessment of treatment effect to the extent that it has become increasingly difficult to develop antidepressant medications appropriate for outperforming placebo. Treatment effect in randomized, placebo-controlled trials, is usually estimated by the mean baseline adjusted difference of treatment response in active and placebo arms and is function of treatment-specific and non-specific effects. The non-specific treatment effect varies subject by subject conditional to the individual propensity to respond to placebo.

View Article and Find Full Text PDF

Comparative analysis of regression algorithms for drug response prediction using GDSC dataset.

BMC Res Notes

January 2025

Department of Computer Engineering, Chungbuk National University, Chungdae-ro 1, Cheongju, 28644, Republic of Korea.

Background: Drug response prediction can infer the relationship between an individual's genetic profile and a drug, which can be used to determine the choice of treatment for an individual patient. Prediction of drug response is recently being performed using machine learning technology. However, high-throughput sequencing data produces thousands of features per patient.

View Article and Find Full Text PDF

Background: Conversational agents (CAs) are finding increasing application in health and social care, not least due to their growing use in the home. Recent developments in artificial intelligence, machine learning, and natural language processing have enabled a variety of new uses for CAs. One type of CA that has received increasing attention recently is smart speakers.

View Article and Find Full Text PDF

Many applications in biomedicine and synthetic bioengineering rely on understanding, mapping, predicting, and controlling the complex behavior of chemical and genetic networks. The emerging field of diverse intelligence investigates the problem-solving capacities of unconventional agents. However, few quantitative tools exist for exploring the competencies of non-conventional systems.

View Article and Find Full Text PDF

Six months of chemotherapy using current agents is standard of care for pulmonary, drug-sensitive tuberculosis (TB), even though some are believed to be cured more rapidly and others require longer therapy. Understanding what factors determine the length of treatment required for durable cure in individual patients would allow individualization of treatment durations, provide better clinical tools to determine the of appropriate duration of new regimens, as well as reduce the cost of large Phase III studies to determine the optimal combinations to use in TB control programs. We conducted a randomized clinical trial in South Africa and China that recruited 704 participants with newly diagnosed, drug-sensitive pulmonary tuberculosis and stratified them based on radiographic disease characteristics as assessed by FDG PET/CT scan readers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!